High-performance IV to support hydration, recovery, energy and reduce pain/inflammation
Dementia specialty care clinicians perspectives on their role in the dementia diagnostic process and diagnostic disclosure
Drawing lessons from other countries approaches to covering GLP-1 drugs, LDI Senior Fellow Ezekiel Emanuel and colleagues give four key guidelines that should inform future policies to ensure fair and effective access to these critical medications across the U.S
However, the recent study on semaglutide, titled Ischemic optic neuropathy with semaglutide: global observational analysis of sex- and formulation-specific risk, published in the British Journal of Ophthalmology (BJO), shows that those using Wegovy are at greater risk of developing no-artertic ischemic optic neuropathy (Naion) than Ozempic
63 A case series linked the use of semaglutide or tirzepatide with an increased risk of NAION, sometimes after a single dose, including in one patient without diabetes and in another who experienced symptoms in both eyes following separate doses
